Related Experiment Video
Updated: Jun 27, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
14.1K
Predicting immune reconstitution after antiretroviral therapy in HIV/AIDS using ensemble machine learning: a
Juan Jin1, Tingting Li2, Jie Chen1
1Department of Infectious Diseases, The Eighth's Hospital of Xi'an, Xi'an, Shaanxi, China.
Frontiers in Immunology
|May 4, 2026
Summary
This study introduces an ensemble learning model for predicting immune recovery in people with HIV on antiretroviral therapy (ART). The model accurately forecasts CD4+ T-cell counts and other immune markers, improving personalized treatment monitoring.
Area of Science:
- Immunology
- Computational Biology
- Data Science
Background:
- Accurate prediction of long-term CD4+ T-cell recovery in people living with HIV (PLWH) on antiretroviral therapy (ART) is essential for personalized monitoring.
- Traditional statistical models struggle with the complex, non-linear longitudinal data common in HIV clinical studies.
Purpose of the Study:
- To develop a robust framework for predicting longitudinal CD4+ T-cell count, CD8+ T-cell count, and CD4/CD8 ratio in PLWH on ART.
- To create a tool that aids in personalized monitoring and treatment optimization for HIV care.
Main Methods:
- Developed a heterogeneous stacking ensemble framework integrating XGBoost, LightGBM, Random Forest, and Gradient Boosting with a Ridge regression meta-learner.
- Trained and tested the model on a retrospective cohort of 5,436 patients, excluding baseline CD4+/CD8+ counts to prevent data leakage.
- Utilized only demographic and clinical features for model training and prediction.
Main Results:
- The ensemble model achieved high predictive accuracy on an independent test set: R² of 0.768 for CD4+ count and 0.636 for CD8+ count.
- Demonstrated significant relative improvements in prediction accuracy compared to a baseline Robust Transformer model (66.4% for CD4+, 128.6% for CD8+).
- The model accurately replicated outcome distributions and showed stable learning dynamics without overfitting.
Conclusions:
- The developed ensemble learning framework is a robust and clinically applicable tool for forecasting immune reconstitution in HIV care.
- This approach offers a foundation for data-driven clinical decision support, enabling personalized long-term treatment monitoring.
- The model's ability to predict immune markers without baseline immunological data enhances its utility for personalized HIV management.
